Microphthalmias are rare disorders whose genetic bases are not fully understood. HMGB3 is a new candidate gene for X-linked forms of this disease.
Supplemental content at jamaophthalmology.com M icrophthalmia can be classified into 2 major forms. In simple microphthalmia, the eye is anatomically normal except for decreased axial length. Complex microphthalmia is characterized by short axial length and anterior and/or posterior segment dysgenesis. Microphthalmia is a heterogeneous condition and both forms may be sporadic or inherited. Microphthalmia may be isolated or occur as one of several other features in various syndromes. The prevalence of microphthalmia has been estimated at 0.2 to 3.0 per 10 000 births. 1, 2 There are at least 6 X-linked loci in the Online Mendelian Inheritance in Man database (http: //omim.org) that include microphthalmia in the phenotype description.
In 1971, Goldberg and McKusick 3 reported a kindred from Maine with X-linked microphthalmos, microcephaly, intellectual disability, and kyphoscoliosis similar to the phenotype (MCOPS1 [OMIM 309800]) first described by Lenz 4 but lacking digit or urogenital abnormalities. Forrester et al 5 mapped the MCOPS1 locus to Xq27-28 in a different family described as having Lenz microphthalmia, and Esmailpour et al 6 identified the mutation in the NAA10 gene (OMIM 300013). We were able to study the original family described by Goldberg and McKusick 3 and identify the genetic basis as an X-linked gene not previously associated with this phenotype. The proband's DNA was analyzed using 2 independent next-generation sequencing technologies, whole-genome sequencing and exome capture of X-linked genes followed by next-generation sequencing. Confirmatory polymerase chain reaction (PCR) and Sanger sequencing were performed on the proband and his mother. In addition, PCR sequencing was used to evaluate the identified candidate gene in unrelated male patients with a similar phenotype.
Methods

Patients
The Johns Hopkins University School of Medicine Institutional Review Board approved this study. Written informed consent was provided for genetic studies from the family described by Goldberg and McKusick. 3 DNA was isolated (Qiagen) from Scope mouthwash collections obtained from the proband and his mother. In addition, DNA was also obtained from 13 unrelated male patients with undiagnosed syndromes of microphthalmia, intellectual disability, and/or additional malformations. Six had colobomatous microphthalmia, with 4 also having intellectual disability. Two patients had bilateral microphthalmia with intellectual disability. Two had microphthalmia and congenital cataracts, 1 of whom also had intellectual disability. One patient each had sclerocornea, bilateral anterior segment dysgenesis, or bilateral anophthalmia. Other malformations included congenital heart or kidney disease in 5 patients and cleft palate and thumb anomalies in 1 patient.
Sequencing
Whole-genome sequencing was performed by Complete Genomics Inc using 10 μg of DNA from the proband. After identification of the suspect variant in the proband, we used PCR and Sanger sequencing of the exon of interest to confirm the mutation in him and his mother. Both PCR and Sanger sequencing were performed for each of the exons of HMGB3 from the 13 unrelated male patients. The PCR primer sequences for the 4 HMGB3 exons are provided in the eTable in the Supplement.
the proband (IV-3) ( Figure 1 ) was an 8-year-old boy who was born at term, weighing approximately 1800 g, below the third percentile. His head circumference was 45.5 cm, which is below the 50th percentile for a child 3 years old. He had intellectual disability, diastema of the upper incisors, and anteverted pinnae with minimal convolutions. He had reported congenital pes varus corrected by special shoes.
The proband also exhibited bilateral ptosis, pendular nystagmus, and right esotropia. There was no light perception in the right eye, and best-corrected visual acuity was 12/400 OS with refraction of +1.00 + 5.00 × 065. Corneal diameters were 3 mm horizontally and vertically in the right eye and 4 mm horizontally and 6 mm vertically in the left eye. Both corneas were clear, and each eye had inferonasal iris coloboma. A posterior segment examination could not be performed in the right eye. However, dilated examination of the left eye revealed a large chorioretinal coloboma that involved the optic nerve.
Three other male family members were noted to have a similar phenotype with colobomatous microphthalmia, blepharoptosis, microcephaly, slow development, and short stature (III-3, III-4, and III-18) (Figure 1) but were unavailable for molecular analysis. The proband's mother had left esotropia and a prominent limbal dermoid temporally in the left eye.
High-Throughput Sequencing Results
Complete Genomics data were aligned to hg19 using the Complete Genomics pipeline version 1.5. Complete Genomics called approximately 9% more bases than the X-exome capture and Illumina sequencing in regions of overlap. Most calls were concordant. We manually inspected discordant positions. Sixty-three positions marked as discordant were not called in Illumina data because of insufficient depth, largely at regions that were near the ends of targeted regions. Nine positions in the Illumina data were not called because of poor mapability.
The region of overlap between the whole-genome sequence from Complete Genomics was compared with sequence data obtained in our laboratory using the Agilent X-exome capture reagent and Illumina sequencing. The filtering cascades for whole-genome and X-exome sequences are listed in Table 1 . Whole-genome sequencing and X-exome capture identified 2 possible candidates ( Table 2 ). The first mutation, PORCN (OMIM 300651), is the human homologue of Drosophila porcupine, mutations in which cause focal dermal hypoplasia (FDH; OMIM 305600). Focal dermal hypoplasia is described as an X-linked dominant trait that affects female carriers. Ninety percent of patients are female, suggesting that it is generally an embryonic lethal for male fetuses. In addition, 95% of cases are sporadic. Microphthalmia is reported as a feature in approximately 15% of cases.
The second mutation was a 2-base pair TA insertion that is predicted to cause a frameshift mutation in the fourth exon of a gene (HMGB3; OMIM 300193) that codes for the evolutionarily conserved high-mobility-group protein HMGB3. The mutation had a PhastCons 9 score of 1 and a PolyPhen2 11 classification of damaging. The insertion was visualized using the Integrative Genomics Viewer 12 (eFigure 1 in the Supplement) and confirmed by Sanger sequencing of exon 4 ( Figure 2) . The variant c.477_478insTA produces the predicted protein change p.Lys161Ilefs*54. Sanger sequencing of the mother confirmed her carrier status (eFigure 2 in the Supplement). We also carefully examined the NAA10 gene for sequence abnormalities that might have been missed by our filtering algorithms; none were found. No other X-linked variants from the whole-genome or X-exome sequencing were strong candidates in terms of potential pathogenicity.
Targeted HMGB3 Sequencing in Male Patients With Related Phenotypes
Thirteen unrelated male patients diagnosed as having microphthalmic conditions of unknown genetic basis were screened for HMGB3 mutations by Sanger sequencing. No variants were identified.
Discussion
We describe a mutation in a kindred with a syndrome with the features of microphthalmia, microcephaly, intellectual disability, and short stature. Using a combination of whole- 6-8 genome sequencing, targeted chromosome X-exome sequencing, and confirmatory Sanger sequencing, we found a mutation in the HMGB3 gene. By combining orthogonal sequencing methods, our ability to identify pathogenic variants was significantly improved over the use of a single technique. As noted above, no other variants with predicted damaging effects were found in the whole-genome or targeted exon sequencing data from the proband. We suggest that the mutation arose in or was passed from the great grandmother (I-1), who had 8 daughters and 1 son. The skewed female to male ratio of offspring may have resulted from the loss of affected males during pregnancy. We have been unable to identify HMGB3 mutations in other patients with microphthalmia phenotypes, and thus the condition reported here is rare. Consequently, we propose that this particular disorder be named Maine microphthalmia (recently designated OMIM 300915) to distinguish it from related phenotypes and as originally suggested by Goldberg and McKusick. 3 HMGB3 is a member of a subfamily of genes thought to play a key role in DNA replication, nucleosome assembly, and transcription. 13 For the related protein HMGB1, the acidic tail was found to interact with histone H3 in the nucleosome to target HMGB1 to nucleosome linker DNA, a binding site for HMGB1 on chromatin. 14 Morpholino knockdown of the Xenopus ortholog, Xhmgb3, was reported to have a significant role in retinal progenitor proliferation during eye development and to produce reduced eye and brain sizes in developing embryos. 15 As can be seen in Figure 3 , the carboxyl terminus of the HMGB3 protein is remarkably conserved in vertebrates. The predicted substitution of the acidic polyglutamic tail with a basic polyarginine domain is expected to have a significant effect on HMGB3 function. Although we cannot entirely rule out that the variant seen in PORCN may be causative and segregate as an X-linked recessive, we believe that the milder phenotype seen in our patient, the neutral 
